181 related articles for article (PubMed ID: 35235139)
21. P2X7 Purinergic Receptor Is Involved in the Pathophysiology of Mania: a Preclinical Study.
Gubert C; Andrejew R; Leite CE; Moritz CEJ; Scholl J; Figueiro F; Kapczinski F; da Silva Magalhães PV; Battastini AMO
Mol Neurobiol; 2020 Mar; 57(3):1347-1360. PubMed ID: 31729632
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
23. Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Jelassi B; Anchelin M; Chamouton J; Cayuela ML; Clarysse L; Li J; Goré J; Jiang LH; Roger S
Carcinogenesis; 2013 Jul; 34(7):1487-96. PubMed ID: 23524196
[TBL] [Abstract][Full Text] [Related]
24. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
25. The interaction between P2X7Rs and T-type calcium ion channels in penicillin-induced epileptiform activity.
Arslan G; Avci B; Kocacan SE; Rzayev E; Ayyildiz M; Agar E
Neuropharmacology; 2019 May; 149():1-12. PubMed ID: 30695710
[TBL] [Abstract][Full Text] [Related]
26. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Ryu JK; Jantaratnotai N; Serrano-Perez MC; McGeer PL; McLarnon JG
J Neuropathol Exp Neurol; 2011 Jan; 70(1):13-22. PubMed ID: 21157381
[TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
Hougardy BM; Maduro JH; van der Zee AG; de Groot DJ; van den Heuvel FA; de Vries EG; de Jong S
Int J Cancer; 2006 Apr; 118(8):1892-900. PubMed ID: 16287099
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
[TBL] [Abstract][Full Text] [Related]
29. Functional P2X
Prades S; Heard G; Gale JE; Engel T; Kopp R; Nicke A; Smith KE; Jagger DJ
J Neurosci; 2021 Mar; 41(12):2615-2629. PubMed ID: 33563723
[TBL] [Abstract][Full Text] [Related]
30. Emerging roles of the P2X7 receptor in cancer pain.
Wu P; Wang Y; Liu Y; Liu Y; Zhou G; Wu X; Wen Q
Purinergic Signal; 2023 Jun; 19(2):441-450. PubMed ID: 36400869
[TBL] [Abstract][Full Text] [Related]
31. P2X7 Receptor Antagonist A804598 Inhibits Inflammation in Brain and Liver in C57BL/6J Mice Exposed to Chronic Ethanol and High Fat Diet.
Freire D; Reyes RE; Baghram A; Davies DL; Asatryan L
J Neuroimmune Pharmacol; 2019 Jun; 14(2):263-277. PubMed ID: 30353422
[TBL] [Abstract][Full Text] [Related]
32. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
[TBL] [Abstract][Full Text] [Related]
33. Electroacupuncture Relieves Nerve Injury-Induced Pain Hypersensitivity via the Inhibition of Spinal P2X7 Receptor-Positive Microglia.
Xu J; Chen XM; Zheng BJ; Wang XR
Anesth Analg; 2016 Mar; 122(3):882-892. PubMed ID: 26599792
[TBL] [Abstract][Full Text] [Related]
34. A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptor.
Zhang Y; Li F; Wang L; Lou Y
Biochem Biophys Res Commun; 2021 Jun; 558():147-153. PubMed ID: 33915328
[TBL] [Abstract][Full Text] [Related]
35. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432.
Lord B; Aluisio L; Shoblock JR; Neff RA; Varlinskaya EI; Ceusters M; Lovenberg TW; Carruthers N; Bonaventure P; Letavic MA; Deak T; Drinkenburg W; Bhattacharya A
J Pharmacol Exp Ther; 2014 Dec; 351(3):628-41. PubMed ID: 25271258
[TBL] [Abstract][Full Text] [Related]
37. P2X7 receptors in neurohypophysial terminals: evidence for their role in arginine-vasopressin secretion.
Cuadra AE; Custer EE; Bosworth EL; Lemos JR
J Cell Physiol; 2014 Mar; 229(3):333-42. PubMed ID: 24037803
[TBL] [Abstract][Full Text] [Related]
38. P2X7 purinergic receptors participate in the expression and extinction processes of contextual fear conditioning memory in mice.
Domingos LB; Hott SC; Terzian ALB; Resstel LBM
Neuropharmacology; 2018 Jan; 128():474-481. PubMed ID: 28802645
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
[TBL] [Abstract][Full Text] [Related]
40. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
